Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,475,256
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
6,832,808
-
Shares change
-
-605,256
-
Total reported value, excl. options
-
$57,884,804
-
Value change
-
-$8,071,620
-
Put/Call ratio
-
20.69%
-
Number of buys
-
32
-
Number of sells
-
-33
-
Price
-
$8.48
Significant Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q1 2022
83 filings reported holding RCEL - AVITA Medical, Inc. - Common Stock as of Q1 2022.
AVITA Medical, Inc. - Common Stock (RCEL) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,832,808 shares
of 26,475,256 outstanding shares and own 25.81% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,567,630 shares), VANGUARD GROUP INC (1,276,977 shares), FARALLON CAPITAL MANAGEMENT LLC (800,000 shares), PURA VIDA INVESTMENTS, LLC (674,316 shares), GEODE CAPITAL MANAGEMENT, LLC (444,706 shares), STATE STREET CORP (419,127 shares), NORTHERN TRUST CORP (216,726 shares), RENAISSANCE TECHNOLOGIES LLC (215,280 shares), AMERIPRISE FINANCIAL INC (111,712 shares), and RTW INVESTMENTS, LP (106,667 shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.